Logo image of ALMCE.PA

MON COURTIER ENERGIE GROUPE (ALMCE.PA) Stock Fundamental Analysis

EPA:ALMCE - Euronext Paris - Matif - FR001400H3A0 - Common Stock - Currency: EUR

5.3  -0.1 (-1.85%)

Fundamental Rating

3

Taking everything into account, ALMCE scores 3 out of 10 in our fundamental rating. ALMCE was compared to 21 industry peers in the Independent Power and Renewable Electricity Producers industry. ALMCE has a great financial health rating, but its profitability evaluates not so good. ALMCE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

ALMCE had positive earnings in the past year.
In the past year ALMCE had a positive cash flow from operations.
ALMCE.PA Yearly Net Income VS EBIT VS OCF VS FCFALMCE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 1M 2M

1.2 Ratios

ALMCE has a Return On Assets (1.32%) which is in line with its industry peers.
ALMCE's Return On Equity of 2.65% is in line compared to the rest of the industry. ALMCE outperforms 52.38% of its industry peers.
ALMCE's Return On Invested Capital of 2.29% is in line compared to the rest of the industry. ALMCE outperforms 47.62% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ALMCE is significantly above the industry average of 4.75%.
The 3 year average ROIC (22.93%) for ALMCE is well above the current ROIC(2.29%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 1.32%
ROE 2.65%
ROIC 2.29%
ROA(3y)12.01%
ROA(5y)N/A
ROE(3y)33.68%
ROE(5y)N/A
ROIC(3y)22.93%
ROIC(5y)N/A
ALMCE.PA Yearly ROA, ROE, ROICALMCE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 10 20 30 40

1.3 Margins

With a Profit Margin value of 1.19%, ALMCE perfoms like the industry average, outperforming 47.62% of the companies in the same industry.
ALMCE's Operating Margin of 1.45% is on the low side compared to the rest of the industry. ALMCE is outperformed by 71.43% of its industry peers.
ALMCE has a Gross Margin (27.36%) which is in line with its industry peers.
Industry RankSector Rank
OM 1.45%
PM (TTM) 1.19%
GM 27.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALMCE.PA Yearly Profit, Operating, Gross MarginsALMCE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 10 20 30

More info and screens

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), ALMCE is creating value.
ALMCE has more shares outstanding than it did 1 year ago.
The debt/assets ratio for ALMCE has been reduced compared to a year ago.
ALMCE.PA Yearly Shares OutstandingALMCE.PA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 1M 2M 3M
ALMCE.PA Yearly Total Debt VS Total AssetsALMCE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 5M 10M 15M

2.2 Solvency

ALMCE has an Altman-Z score of 2.84. This is not the best score and indicates that ALMCE is in the grey zone with still only limited risk for bankruptcy at the moment.
ALMCE has a Altman-Z score of 2.84. This is in the better half of the industry: ALMCE outperforms 71.43% of its industry peers.
The Debt to FCF ratio of ALMCE is 2.68, which is a good value as it means it would take ALMCE, 2.68 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ALMCE (2.68) is better than 95.24% of its industry peers.
ALMCE has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
ALMCE has a better Debt to Equity ratio (0.01) than 90.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 2.68
Altman-Z 2.84
ROIC/WACC0.29
WACC7.86%
ALMCE.PA Yearly LT Debt VS Equity VS FCFALMCE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 2M 4M 6M 8M 10M

2.3 Liquidity

A Current Ratio of 1.84 indicates that ALMCE should not have too much problems paying its short term obligations.
ALMCE has a better Current ratio (1.84) than 66.67% of its industry peers.
A Quick Ratio of 1.84 indicates that ALMCE should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.84, ALMCE is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.84
Quick Ratio 1.84
ALMCE.PA Yearly Current Assets VS Current LiabilitesALMCE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 5M 10M 15M

More info and screens

2

3. Growth

3.1 Past

ALMCE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -73.94%.
ALMCE shows a small growth in Revenue. In the last year, the Revenue has grown by 6.15%.
EPS 1Y (TTM)-73.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-144.71%
Revenue 1Y (TTM)6.15%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%13.18%

3.2 Future

Based on estimates for the next years, ALMCE will show a small growth in Earnings Per Share. The EPS will grow by 6.92% on average per year.
ALMCE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.14% yearly.
EPS Next Y-61.11%
EPS Next 2Y-55.9%
EPS Next 3Y6.92%
EPS Next 5YN/A
Revenue Next Year17.62%
Revenue Next 2Y13.18%
Revenue Next 3Y16.14%
Revenue Next 5YN/A

3.3 Evolution

ALMCE.PA Yearly Revenue VS EstimatesALMCE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 10M 20M 30M
ALMCE.PA Yearly EPS VS EstimatesALMCE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 0.1 0.2 0.3 0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 53.00 indicates a quite expensive valuation of ALMCE.
ALMCE's Price/Earnings ratio is a bit more expensive when compared to the industry. ALMCE is more expensive than 61.90% of the companies in the same industry.
ALMCE is valuated expensively when we compare the Price/Earnings ratio to 26.32, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 73.51 indicates a quite expensive valuation of ALMCE.
ALMCE's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. ALMCE is more expensive than 61.90% of the companies in the same industry.
ALMCE's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.19.
Industry RankSector Rank
PE 53
Fwd PE 73.51
ALMCE.PA Price Earnings VS Forward Price EarningsALMCE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

61.90% of the companies in the same industry are cheaper than ALMCE, based on the Enterprise Value to EBITDA ratio.
61.90% of the companies in the same industry are more expensive than ALMCE, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 114.78
EV/EBITDA 25.15
ALMCE.PA Per share dataALMCE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-55.9%
EPS Next 3Y6.92%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALMCE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MON COURTIER ENERGIE GROUPE

EPA:ALMCE (6/17/2025, 7:00:00 PM)

5.3

-0.1 (-1.85%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.33%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap19.40M
Analysts84.44
Price Target6.63 (25.09%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 53
Fwd PE 73.51
P/S 0.87
P/FCF 114.78
P/OCF 38.41
P/B 1.93
P/tB 2.64
EV/EBITDA 25.15
EPS(TTM)0.1
EY1.89%
EPS(NY)0.07
Fwd EY1.36%
FCF(TTM)0.05
FCFY0.87%
OCF(TTM)0.14
OCFY2.6%
SpS6.13
BVpS2.75
TBVpS2.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.32%
ROE 2.65%
ROCE 3%
ROIC 2.29%
ROICexc 8.81%
ROICexgc 167.3%
OM 1.45%
PM (TTM) 1.19%
GM 27.36%
FCFM 0.75%
ROA(3y)12.01%
ROA(5y)N/A
ROE(3y)33.68%
ROE(5y)N/A
ROIC(3y)22.93%
ROIC(5y)N/A
ROICexc(3y)137.77%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)29.61%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.11
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 2.68
Debt/EBITDA 0.31
Cap/Depr 243.48%
Cap/Sales 1.5%
Interest Coverage 250
Cash Conversion 109.31%
Profit Quality 63.53%
Current Ratio 1.84
Quick Ratio 1.84
Altman-Z 2.84
F-Score4
WACC7.86%
ROIC/WACC0.29
Cap/Depr(3y)79.03%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.26%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-73.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-144.71%
EPS Next Y-61.11%
EPS Next 2Y-55.9%
EPS Next 3Y6.92%
EPS Next 5YN/A
Revenue 1Y (TTM)6.15%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%13.18%
Revenue Next Year17.62%
Revenue Next 2Y13.18%
Revenue Next 3Y16.14%
Revenue Next 5YN/A
EBIT growth 1Y-83.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-52.94%
EBIT Next 3Y10.6%
EBIT Next 5YN/A
FCF growth 1Y-132.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-128.03%
OCF growth 3YN/A
OCF growth 5YN/A